首页 > 最新文献

Nagoya Journal of Medical Science最新文献

英文 中文
Job satisfaction among Myanmar working population, a cross-sectional study. 缅甸劳动人口的工作满意度,一项横断面研究。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2023-08-01 DOI: 10.18999/nagjms.85.3.444
Pa Pa Soe, Su Yi Toe, Zar Lwin Hnin, Ma Ma Thant, Nyi Nyi Latt, Nang Hla Hla Htay, Than Than Aung, Myint Sann, Nang Hla Hla Win

The gap between expectations and reality could lead to low job satisfaction. Although much literature has been described on job satisfaction among different categories of people, more research is needed to acknowledge the judgment of job satisfaction among some of the Myanmar working population. The study aims to find out the satisfaction level of a job and the factors related to it. The cross-sectional study was conducted in January 2019 by calling for face-to-face interviews with 536 respondents selected using a convenient sampling technique using a pre-tested questionnaire. The highest satisfied respondents were >50 years age group (86.11%), females (71.89%), higher officials (90.53%), and more than three years of service (78.35%). In the adjusted analysis, having 41-50 year age group (AOR 2.72; 95% CI: 1.08-6.83), part-time job nature (AOR 2.16; 95% CI: 1.17-3.99), and the higher official (AOR 5.71; 95% CI: 2.48-13.13) were significantly associated with job satisfaction. Relationships with the direct executive and, organization and management were the main determinants of job satisfaction. Moreover, the respondents with higher positions were more likely to have higher job satisfaction in the study.

期望与现实之间的差距可能导致工作满意度低。尽管已经有很多文献描述了不同类别人群的工作满意度,但还需要更多的研究来确认缅甸一些劳动人口对工作满意度的判断。这项研究旨在了解工作的满意度及其相关因素。这项横断面研究于2019年1月进行,对536名受访者进行了面对面采访,这些受访者使用方便的抽样技术,使用预先测试的问卷进行了选择。满意度最高的受访者是50岁以上年龄组(86.11%)、女性(71.89%)、高级官员(90.53%)和服务三年以上(78.35%)。在调整后的分析中,41-50岁年龄组(AOR 2.72;95%CI:1.08-6.83)、兼职性质(AOR 2.16;95%CI:1.17-3.99),高级官员(AOR 5.71;95%CI:2.48-13.13)与工作满意度显著相关。与直接执行官、组织和管理层的关系是工作满意度的主要决定因素。此外,在研究中,职位较高的受访者更有可能拥有更高的工作满意度。
{"title":"Job satisfaction among Myanmar working population, a cross-sectional study.","authors":"Pa Pa Soe,&nbsp;Su Yi Toe,&nbsp;Zar Lwin Hnin,&nbsp;Ma Ma Thant,&nbsp;Nyi Nyi Latt,&nbsp;Nang Hla Hla Htay,&nbsp;Than Than Aung,&nbsp;Myint Sann,&nbsp;Nang Hla Hla Win","doi":"10.18999/nagjms.85.3.444","DOIUrl":"10.18999/nagjms.85.3.444","url":null,"abstract":"<p><p>The gap between expectations and reality could lead to low job satisfaction. Although much literature has been described on job satisfaction among different categories of people, more research is needed to acknowledge the judgment of job satisfaction among some of the Myanmar working population. The study aims to find out the satisfaction level of a job and the factors related to it. The cross-sectional study was conducted in January 2019 by calling for face-to-face interviews with 536 respondents selected using a convenient sampling technique using a pre-tested questionnaire. The highest satisfied respondents were >50 years age group (86.11%), females (71.89%), higher officials (90.53%), and more than three years of service (78.35%). In the adjusted analysis, having 41-50 year age group (AOR 2.72; 95% CI: 1.08-6.83), part-time job nature (AOR 2.16; 95% CI: 1.17-3.99), and the higher official (AOR 5.71; 95% CI: 2.48-13.13) were significantly associated with job satisfaction. Relationships with the direct executive and, organization and management were the main determinants of job satisfaction. Moreover, the respondents with higher positions were more likely to have higher job satisfaction in the study.</p>","PeriodicalId":49014,"journal":{"name":"Nagoya Journal of Medical Science","volume":"85 3","pages":"444-454"},"PeriodicalIF":0.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/19/0b/2186-3326-85-0444.PMC10565578.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41217150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urethral identification using three-dimensional magnetic resonance imaging and interfraction urethral motion evaluation for prostate stereotactic body radiotherapy. 三维磁共振成像的尿道识别和前列腺立体定向体放射治疗中尿道运动评估。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2023-08-01 DOI: 10.18999/nagjms.85.3.504
Yutaka Kato, Shintaro Okumiya, Kuniyasu Okudaira, Junji Ito, Motoki Kumagai, Takeshi Kamomae, Yumiko Noguchi, Mariko Kawamura, Shunichi Ishihara, Shinji Naganawa

Prostatic urethra identification is crucial in prostate stereotactic body radiotherapy (SBRT) to reduce the risk of urinary toxicity. Although computed tomography (CT) with a catheter is commonly employed, it is invasive, and catheter placement may displace the urethral position, resulting in possible planning inaccuracies. However, magnetic resonance imaging (MRI) can overcome these weaknesses. Accurate urethral identification and minimal daily variation could ensure a highly accurate SBRT. In this study, we investigated the usefulness of a three-dimensional (3D) T2-weighted (T2W) sequence for urethral identification, and the interfractional motion of the prostatic urethra on CT with a catheter and MRI without a catheter for implementing noninvasive SBRT. Thirty-two patients were divided into three groups. The first group underwent MRI without a catheter to evaluate urethral identification by two-dimensional (2D)- and 3D-T2W sequences using mean slice-wise Hausdorff distance (MSHD) and Dice similarity coefficient (DSC) of the contouring by two operators and using visual assessment. The second group provided 3-day MRI data without a catheter using 3D-T2W, and the third provided 3-day CT data with a catheter to evaluate the interfractional motion using MSHD, DSC, and displacement distance (Dd). The MSHD and DSC for the interoperator variability in urethral identification and visual assessment were superior in 3D-T2W than in 2D-T2W. Regarding interfractional motion, the Dd value for prostatic urethra was smaller in MRI than in CT. These findings indicate that the 3D-T2W yielded adequate prostatic urethral identification, and catheter-free MRI resulted in less interfractional motion, suggesting that 3D-T2W MRI without a catheter is a feasible noninvasive approach to performing prostate SBRT.

前列腺尿道识别在前列腺立体定向体放射治疗(SBRT)中至关重要,以降低尿毒性的风险。尽管通常使用带导管的计算机断层扫描(CT),但它具有侵入性,并且导管的放置可能会使尿道位置移位,从而导致可能的计划不准确。然而,磁共振成像(MRI)可以克服这些弱点。准确的尿道识别和最小的每日变异可以确保高度准确的SBRT。在本研究中,我们研究了三维(3D)T2加权(T2W)序列在尿道识别中的有用性,以及在有导管的CT和无导管的MRI上前列腺尿道的交叉运动,以实现无创SBRT。32名患者被分为三组。第一组在没有导管的情况下接受MRI检查,通过二维(2D)和3D-T2W序列评估尿道识别,使用两名操作员轮廓的平均切片Hausdorff距离(MSHD)和Dice相似系数(DSC),并使用视觉评估。第二组使用3D-T2W在没有导管的情况下提供了3天的MRI数据,第三组使用MSHD、DSC和位移距离(Dd)提供了有导管的3天CT数据以评估交叉运动。MSHD和DSC在尿道识别和视觉评估的互操作变异性方面在3D-T2W中优于2D-T2W。关于交叉运动,MRI中前列腺尿道的Dd值小于CT。这些发现表明,3D-T2W可以充分识别前列腺尿道,而无导管MRI导致较少的交叉运动,这表明无导管的3D-T2WMRI是一种可行的无创前列腺SBRT方法。
{"title":"Urethral identification using three-dimensional magnetic resonance imaging and interfraction urethral motion evaluation for prostate stereotactic body radiotherapy.","authors":"Yutaka Kato,&nbsp;Shintaro Okumiya,&nbsp;Kuniyasu Okudaira,&nbsp;Junji Ito,&nbsp;Motoki Kumagai,&nbsp;Takeshi Kamomae,&nbsp;Yumiko Noguchi,&nbsp;Mariko Kawamura,&nbsp;Shunichi Ishihara,&nbsp;Shinji Naganawa","doi":"10.18999/nagjms.85.3.504","DOIUrl":"10.18999/nagjms.85.3.504","url":null,"abstract":"<p><p>Prostatic urethra identification is crucial in prostate stereotactic body radiotherapy (SBRT) to reduce the risk of urinary toxicity. Although computed tomography (CT) with a catheter is commonly employed, it is invasive, and catheter placement may displace the urethral position, resulting in possible planning inaccuracies. However, magnetic resonance imaging (MRI) can overcome these weaknesses. Accurate urethral identification and minimal daily variation could ensure a highly accurate SBRT. In this study, we investigated the usefulness of a three-dimensional (3D) T2-weighted (T2W) sequence for urethral identification, and the interfractional motion of the prostatic urethra on CT with a catheter and MRI without a catheter for implementing noninvasive SBRT. Thirty-two patients were divided into three groups. The first group underwent MRI without a catheter to evaluate urethral identification by two-dimensional (2D)- and 3D-T2W sequences using mean slice-wise Hausdorff distance (MSHD) and Dice similarity coefficient (DSC) of the contouring by two operators and using visual assessment. The second group provided 3-day MRI data without a catheter using 3D-T2W, and the third provided 3-day CT data with a catheter to evaluate the interfractional motion using MSHD, DSC, and displacement distance (Dd). The MSHD and DSC for the interoperator variability in urethral identification and visual assessment were superior in 3D-T2W than in 2D-T2W. Regarding interfractional motion, the Dd value for prostatic urethra was smaller in MRI than in CT. These findings indicate that the 3D-T2W yielded adequate prostatic urethral identification, and catheter-free MRI resulted in less interfractional motion, suggesting that 3D-T2W MRI without a catheter is a feasible noninvasive approach to performing prostate SBRT.</p>","PeriodicalId":49014,"journal":{"name":"Nagoya Journal of Medical Science","volume":"85 3","pages":"504-517"},"PeriodicalIF":0.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/aa/58/2186-3326-85-0504.PMC10565580.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41217173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlations of high molecular weight adiponectin, tumor necrosis factor-alpha and vascular endothelial growth factors with occurrence of colonic polyps in the prediabetic population. 糖尿病前期人群中高分子量脂联素、肿瘤坏死因子α和血管内皮生长因子与结肠息肉发生的相关性。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2023-08-01 DOI: 10.18999/nagjms.85.3.465
Huafen Zhang, Lilan Zhou, Junjun Zhu

We aimed to explore the correlations of high molecular weight adiponectin (HMW-ADP), tumor necrosis factor-alpha (TNF-α) and vascular endothelial growth factors (VEGFs) with the occurrence of colonic polyps in the prediabetic population. Two hundred patients with prediabetes were enrolled, and their clinical data were retrospectively analyzed. They were divided into group A (75 patients with colonic polyps) and group B (125 patients without colonic polyps). Eighty patients with normal glucose tolerance in the same period were divided into group C (32 patients with normal glucose tolerance and colonic polyps) and group D (48 patients with normal glucose tolerance but no colonic polyps). The correlations of serum HMW-ADP, TNF-α and VEGF levels with plasma glucose and insulin levels were explored by Pearson's analysis. The factors influencing the occurrence of colonic polyps were determined by logistic regression analysis. Serum HMW-ADP was negatively correlated with TNF-α, VEGFs, FPG, 2hPG, FI and HOMA-IR (r<0, P<0.05), whereas serum TNF-α and VEGFs were positively correlated with FPG, 2hPG, FI and HOMA-IR (r>0, P<0.05). Age, body mass index, waist-to-hip ratio, history of smoking, history of drinking, family history of colon cancer, TNF-α and VEGF were independent risk factors [odds ratio (OR)>1, P<0.05], and HMW-ADP was a protective factor (OR<1, P<0.05). The areas under the curves of serum HMW-ADP, TNF-α, VEGFs and their combination for predicting the occurrence of colonic polyps were 0.899, 0.787, 0.908 and 0.922, respectively. The combination of HMW-ADP, TNF-α and VEGFs can effectively predict the occurrence of colonic polyps in prediabetic patients.

我们旨在探讨高分子量脂联素(HMW-ADP)、肿瘤坏死因子-α(TNF-α)和血管内皮生长因子(VEGFs)与糖尿病前期人群结肠息肉发生的相关性。对200例糖尿病前期患者进行了回顾性分析。他们被分为A组(75例有结肠息肉的患者)和B组(125例无结肠息肉的病人)。将同期糖耐量正常的80例患者分为C组(32例葡萄糖耐量正常并伴有结肠息肉)和D组(48例糖耐量异常但无结肠息肉)。通过Pearson分析探讨血清HMW-ADP、TNF-α和VEGF水平与血糖和胰岛素水平的相关性。通过逻辑回归分析确定影响结肠息肉发生的因素。血清HMW-ADP与TNF-α、VEGFs、FPG、2hPG、FI和HOMA-IR呈负相关(rr>0,P1,P
{"title":"Correlations of high molecular weight adiponectin, tumor necrosis factor-alpha and vascular endothelial growth factors with occurrence of colonic polyps in the prediabetic population.","authors":"Huafen Zhang, Lilan Zhou, Junjun Zhu","doi":"10.18999/nagjms.85.3.465","DOIUrl":"10.18999/nagjms.85.3.465","url":null,"abstract":"<p><p>We aimed to explore the correlations of high molecular weight adiponectin (HMW-ADP), tumor necrosis factor-alpha (TNF-α) and vascular endothelial growth factors (VEGFs) with the occurrence of colonic polyps in the prediabetic population. Two hundred patients with prediabetes were enrolled, and their clinical data were retrospectively analyzed. They were divided into group A (75 patients with colonic polyps) and group B (125 patients without colonic polyps). Eighty patients with normal glucose tolerance in the same period were divided into group C (32 patients with normal glucose tolerance and colonic polyps) and group D (48 patients with normal glucose tolerance but no colonic polyps). The correlations of serum HMW-ADP, TNF-α and VEGF levels with plasma glucose and insulin levels were explored by Pearson's analysis. The factors influencing the occurrence of colonic polyps were determined by logistic regression analysis. Serum HMW-ADP was negatively correlated with TNF-α, VEGFs, FPG, 2hPG, FI and HOMA-IR (<i>r</i><0, P<0.05), whereas serum TNF-α and VEGFs were positively correlated with FPG, 2hPG, FI and HOMA-IR (<i>r</i>>0, P<0.05). Age, body mass index, waist-to-hip ratio, history of smoking, history of drinking, family history of colon cancer, TNF-α and VEGF were independent risk factors [odds ratio (OR)>1, P<0.05], and HMW-ADP was a protective factor (OR<1, P<0.05). The areas under the curves of serum HMW-ADP, TNF-α, VEGFs and their combination for predicting the occurrence of colonic polyps were 0.899, 0.787, 0.908 and 0.922, respectively. The combination of HMW-ADP, TNF-α and VEGFs can effectively predict the occurrence of colonic polyps in prediabetic patients.</p>","PeriodicalId":49014,"journal":{"name":"Nagoya Journal of Medical Science","volume":"85 3","pages":"465-475"},"PeriodicalIF":0.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/28/db/2186-3326-85-0465.PMC10565577.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41217148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends of travel burdens to access cancer care among children with cancer: analysis of a population-based cancer registry data in Aichi, Japan. 癌症儿童获得癌症治疗的旅行负担趋势:对日本爱知市基于人口的癌症登记数据的分析。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2023-08-01 DOI: 10.18999/nagjms.85.3.542
Anna Tsutsui, Natsumiko Ando, Yukari Taniyama, Takako Fujimaki, Masanori Kawaura, Keitaro Matsuo, Hidemi Ito, Yuko Ohno

Centralization of childhood cancer treatment in specialized hospitals is necessary for quality treatment and care, but imposes a time and cost burden for patients and their families. We investigated the 20-year trend in the patients' car travel burden to reach cancer-care hospitals in Aichi Prefecture, Japan. From the Aichi population-based cancer registry data, 1,741 cases diagnosed in 1998-2017 under 15 years of age were extracted and assigned to three treatment groups: invasive treatment (n = 697), radiotherapy (n = 371), or chemotherapy groups (n = 1,462), allowing for duplicate assignment. Their travels to access each treatment hospital were estimated and summarized as the estimated travel times (ETT), estimated travel distances (ETD), and direct distances (DD). The ETTs were compared using the Brunner-Munzel test. The average cases per year for each hospital were plotted. The annual trends during 1998-2017 on ETT, ETD, and DD were investigated using Joinpoint regression models. The ETTs were 0.38-0.45 hours on median for three periods (1998-2005, 2006-2012, and 2013-2017) in three treatment groups and increased by 0.02-0.07 hours from 2006-2012 to 2013-2017, with a statistically significant difference in the radiotherapy group (0.07 hours, P = 0.037). The average cases per year increased for the top hospital in each group, and regression model analyses showed no joinpoint on the annual median trend. In conclusion, the increases in travel times were small and not considered clinically significant, and treatment centralization was observed from 2006-2012 to 2013-2017.

将儿童癌症治疗集中在专科医院对于高质量的治疗和护理是必要的,但这给患者及其家人带来了时间和成本负担。我们调查了日本爱知县患者前往癌症专科医院的汽车旅行负担的20年趋势。从爱知市基于人群的癌症登记数据中,提取1998年至2017年诊断为15岁以下的1741例病例,并将其分为三个治疗组:侵入性治疗(n=697)、放射治疗(n=371)或化疗组(n=1462),允许重复分配。他们前往各治疗医院的行程被估计并总结为估计行程时间(ETT)、估计行程距离(ETD)和直接距离(DD)。使用Brunner-Munzel检验对ETT进行比较。绘制了每家医院每年的平均病例数。使用Joinpoint回归模型研究了1998-2017年间ETT、ETD和DD的年度趋势。三个治疗组的ETT在三个时期(1998-2005年、2006-2012年和2013-2017年)的中位数为0.38-0.45小时,从2006-2012年到2013-2017年增加了0.02-0.07小时,放疗组的差异具有统计学意义(0.07小时,P=0.037),回归模型分析表明,年中位数趋势没有连接点。总之,旅行时间的增加很小,不具有临床意义,2006-2012年至2013-2017年期间观察到治疗集中。
{"title":"Trends of travel burdens to access cancer care among children with cancer: analysis of a population-based cancer registry data in Aichi, Japan.","authors":"Anna Tsutsui,&nbsp;Natsumiko Ando,&nbsp;Yukari Taniyama,&nbsp;Takako Fujimaki,&nbsp;Masanori Kawaura,&nbsp;Keitaro Matsuo,&nbsp;Hidemi Ito,&nbsp;Yuko Ohno","doi":"10.18999/nagjms.85.3.542","DOIUrl":"10.18999/nagjms.85.3.542","url":null,"abstract":"<p><p>Centralization of childhood cancer treatment in specialized hospitals is necessary for quality treatment and care, but imposes a time and cost burden for patients and their families. We investigated the 20-year trend in the patients' car travel burden to reach cancer-care hospitals in Aichi Prefecture, Japan. From the Aichi population-based cancer registry data, 1,741 cases diagnosed in 1998-2017 under 15 years of age were extracted and assigned to three treatment groups: invasive treatment (n = 697), radiotherapy (n = 371), or chemotherapy groups (n = 1,462), allowing for duplicate assignment. Their travels to access each treatment hospital were estimated and summarized as the estimated travel times (ETT), estimated travel distances (ETD), and direct distances (DD). The ETTs were compared using the Brunner-Munzel test. The average cases per year for each hospital were plotted. The annual trends during 1998-2017 on ETT, ETD, and DD were investigated using Joinpoint regression models. The ETTs were 0.38-0.45 hours on median for three periods (1998-2005, 2006-2012, and 2013-2017) in three treatment groups and increased by 0.02-0.07 hours from 2006-2012 to 2013-2017, with a statistically significant difference in the radiotherapy group (0.07 hours, <i>P</i> = 0.037). The average cases per year increased for the top hospital in each group, and regression model analyses showed no joinpoint on the annual median trend. In conclusion, the increases in travel times were small and not considered clinically significant, and treatment centralization was observed from 2006-2012 to 2013-2017.</p>","PeriodicalId":49014,"journal":{"name":"Nagoya Journal of Medical Science","volume":"85 3","pages":"542-554"},"PeriodicalIF":0.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/30/93/2186-3326-85-0542.PMC10565588.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41217172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
<Editors' Choice> Comparison of clinical features between patients with acute exacerbation of idiopathic interstitial pneumonia and collagen vascular disease-associated interstitial pneumonia. <编辑的选择>特发性间质性肺炎急性加重期和胶原血管病相关性间质性疾病患者的临床特征比较。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2023-08-01 DOI: 10.18999/nagjms.85.3.602
Yuki Kata, Yu Hara, Kota Murohashi, Yusuke Saigusa, Ryo Nagasawa, Yoichi Tagami, Hiroaki Fujii, Ayako Aoki, Yurika Nishikawa, Katsushi Tanaka, Keisuke Watanabe, Nobuyuki Horita, Nobuaki Kobayashi, Masaki Yamamoto, Makoto Kudo, Takeshi Kaneko

Acute exacerbation (AE) of interstitial pneumonia (IP) shows poor prognosis, due to the typical histological pattern of diffuse alveolar damage superimposed upon lung fibrosis. The previous reports comparing clinical features between AE of idiopathic interstitial pneumonias (IIPs) and those of IPs with known etiology are limited. We retrospectively compared clinical parameters including age, sex, Charlson Comorbidity Index score (CCIS), blood biomarkers at diagnosis of AE, treatment, and 3-month mortality between patients with AE of IIPs and collagen vascular disease-associated interstitial pneumonia (CVD-IP). We assessed 85 patients, comprising 66 patients with AE of IIPs (78%) and 19 patients with AE of CVD-IP (22%). The least absolute shrinkage and selection operator regression selected CCIS (hazard ratio, 1.281; 95% confidence interval, 1.055-1.556; P = 0.012) and log serum lactate dehydrogenase (LDH) (hazard ratio, 6.267; 95% confidence interval, 2.172-18.085; P < 0.001) as significant predictors of 3-month mortality among these patients. Also, the adjusted survival curves using sex, CCIS, and serum LDH showed no significant differences between these two groups. In conclusion, among AE patients, CCIS and serum LDH level may be more important prognostic factors for 3-month mortality rather than two classification of IP subtypes: IIPs and CVD-IP.

间质性肺炎(IP)的急性加重(AE)显示预后不良,这是由于弥漫性肺泡损伤叠加肺纤维化的典型组织学模式。先前比较特发性间质性肺炎(IIPs)AE和已知病因的IPs AE的临床特征的报道是有限的。我们回顾性比较了IIPs AE和胶原血管病相关性间质性肺炎(CVD-IP)患者的临床参数,包括年龄、性别、Charlson共病指数评分(CCIS)、诊断AE时的血液生物标志物、治疗和3个月死亡率。我们评估了85名患者,包括66名IIP AE患者(78%)和19名CVD-IP AE患者(22%)。最小绝对收缩和选择算子回归选择CCIS(危险比,1.281;95%置信区间,1.055-1.556;P=0.012)和对数血清乳酸脱氢酶(LDH)(危险比:6.267;95%可信区间,2.172-18.085;P<0.001)作为这些患者3个月死亡率的显著预测因素。此外,使用性别、CCIS和血清LDH的调整生存曲线在这两组之间没有显示出显著差异。总之,在AE患者中,CCIS和血清LDH水平可能是3个月死亡率的更重要的预后因素,而不是IP亚型的两种分类:IIPs和CVD-IP。
{"title":"<Editors' Choice> Comparison of clinical features between patients with acute exacerbation of idiopathic interstitial pneumonia and collagen vascular disease-associated interstitial pneumonia.","authors":"Yuki Kata,&nbsp;Yu Hara,&nbsp;Kota Murohashi,&nbsp;Yusuke Saigusa,&nbsp;Ryo Nagasawa,&nbsp;Yoichi Tagami,&nbsp;Hiroaki Fujii,&nbsp;Ayako Aoki,&nbsp;Yurika Nishikawa,&nbsp;Katsushi Tanaka,&nbsp;Keisuke Watanabe,&nbsp;Nobuyuki Horita,&nbsp;Nobuaki Kobayashi,&nbsp;Masaki Yamamoto,&nbsp;Makoto Kudo,&nbsp;Takeshi Kaneko","doi":"10.18999/nagjms.85.3.602","DOIUrl":"10.18999/nagjms.85.3.602","url":null,"abstract":"<p><p>Acute exacerbation (AE) of interstitial pneumonia (IP) shows poor prognosis, due to the typical histological pattern of diffuse alveolar damage superimposed upon lung fibrosis. The previous reports comparing clinical features between AE of idiopathic interstitial pneumonias (IIPs) and those of IPs with known etiology are limited. We retrospectively compared clinical parameters including age, sex, Charlson Comorbidity Index score (CCIS), blood biomarkers at diagnosis of AE, treatment, and 3-month mortality between patients with AE of IIPs and collagen vascular disease-associated interstitial pneumonia (CVD-IP). We assessed 85 patients, comprising 66 patients with AE of IIPs (78%) and 19 patients with AE of CVD-IP (22%). The least absolute shrinkage and selection operator regression selected CCIS (hazard ratio, 1.281; 95% confidence interval, 1.055-1.556; P = 0.012) and log serum lactate dehydrogenase (LDH) (hazard ratio, 6.267; 95% confidence interval, 2.172-18.085; P < 0.001) as significant predictors of 3-month mortality among these patients. Also, the adjusted survival curves using sex, CCIS, and serum LDH showed no significant differences between these two groups. In conclusion, among AE patients, CCIS and serum LDH level may be more important prognostic factors for 3-month mortality rather than two classification of IP subtypes: IIPs and CVD-IP.</p>","PeriodicalId":49014,"journal":{"name":"Nagoya Journal of Medical Science","volume":"85 3","pages":"602-611"},"PeriodicalIF":0.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b7/64/2186-3326-85-0602.PMC10565576.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41217127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between National Institutes of Health Stroke Scale and Functional Independence Measure scores in patients with ischemic stroke from convalescent rehabilitation outcomes. 美国国立卫生研究院脑卒中量表与缺血性脑卒中患者恢复期康复结果的功能独立性测量评分之间的关联。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2023-08-01 DOI: 10.18999/nagjms.85.3.428
Joe Senda, Keiichi Ito, Tomomitsu Kotake, Masanori Mizuno, Hideo Kishimoto, Keizo Yasui, Hiroko Nakagawa-Senda, Masahisa Katsuno, Yoshihiro Nishida, Gen Sobue

We investigated the associations among neurological severity, activities of daily living (ADLs), and clinical factors in patients with ischemic stroke in convalescent rehabilitation outcome. The study sample included 723 patients with ischemic stroke (484 men and 239 women; mean age, 73.2 ± 8.5 years) for inpatient convalescent rehabilitation. National Institutes of Health Stroke Scale (NIHSS) was used to measure the neurological severity, and Functional Independence Measure (FIM) was used to assess ADLs at discharge. Leukoaraiosis was graded based on periventricular hyperintensity (PVH) and deep white matter hyperintensity (DWMH) on magnetic resonance imaging. The correlations between NIHSS scores and total FIM scores were significant but relatively mild (r = -0.684, P < 0.001). Multiple regression analysis revealed that age and PVH grade significantly decreased their total FIM scores and affected the discrepancies between NIHSS scores at discharge (P < 0.001), but DWMH scores did not affect these results. Factors such as positive history of heart disease (P = 0.008) and bilateral infarction (P = 0.038) additionally decreased their total FIM scores and affected the discrepancies between NIHSS scores. These findings suggest that age, PVH, history of heart disease positive, and bilateral infarction in patients with ischemic stroke affected their performance of ADLs and the discrepancies between their neurological severities in convalescent rehabilitation outcomes, probably because the pathophysiological background of leukoaraiosis and these factors strongly decrease their ADL performance in post-phase ischemic stroke.

我们研究了缺血性脑卒中患者恢复期康复结果中神经系统严重程度、日常生活能力(ADL)和临床因素之间的关系。研究样本包括723名缺血性中风患者(484名男性和239名女性;平均年龄73.2±8.5岁),接受住院康复治疗。美国国立卫生研究院卒中量表(NIHSS)用于测量神经系统的严重程度,功能独立性测量(FIM)用于评估出院时的ADL。根据磁共振成像上的室周高信号(PVH)和深白质高信号(DWMH)对脑白质病进行分级。NIHSS评分与FIM总分之间的相关性显著但相对较轻(r=-0.684,P<0.001)。多元回归分析显示,年龄和PVH分级显著降低了他们的FIM总分,并影响了出院时NIHSS评分之间的差异(P<0.001),但DWMH评分不影响这些结果。心脏病阳性史(P=0.008)和双侧梗死(P=0.038)等因素还降低了他们的FIM总分,并影响了NIHSS评分之间的差异。这些发现表明,缺血性中风患者的年龄、PVH、心脏病阳性史和双侧梗死影响了他们的ADL表现,以及他们在恢复期康复结果中的神经严重程度之间的差异,可能是因为脑白质疏松症的病理生理背景和这些因素强烈降低了他们在缺血性卒中后期的ADL表现。
{"title":"Association between National Institutes of Health Stroke Scale and Functional Independence Measure scores in patients with ischemic stroke from convalescent rehabilitation outcomes.","authors":"Joe Senda,&nbsp;Keiichi Ito,&nbsp;Tomomitsu Kotake,&nbsp;Masanori Mizuno,&nbsp;Hideo Kishimoto,&nbsp;Keizo Yasui,&nbsp;Hiroko Nakagawa-Senda,&nbsp;Masahisa Katsuno,&nbsp;Yoshihiro Nishida,&nbsp;Gen Sobue","doi":"10.18999/nagjms.85.3.428","DOIUrl":"10.18999/nagjms.85.3.428","url":null,"abstract":"<p><p>We investigated the associations among neurological severity, activities of daily living (ADLs), and clinical factors in patients with ischemic stroke in convalescent rehabilitation outcome. The study sample included 723 patients with ischemic stroke (484 men and 239 women; mean age, 73.2 ± 8.5 years) for inpatient convalescent rehabilitation. National Institutes of Health Stroke Scale (NIHSS) was used to measure the neurological severity, and Functional Independence Measure (FIM) was used to assess ADLs at discharge. Leukoaraiosis was graded based on periventricular hyperintensity (PVH) and deep white matter hyperintensity (DWMH) on magnetic resonance imaging. The correlations between NIHSS scores and total FIM scores were significant but relatively mild (r = -0.684, <i>P</i> < 0.001). Multiple regression analysis revealed that age and PVH grade significantly decreased their total FIM scores and affected the discrepancies between NIHSS scores at discharge (<i>P</i> < 0.001), but DWMH scores did not affect these results. Factors such as positive history of heart disease (<i>P</i> = 0.008) and bilateral infarction (<i>P</i> = 0.038) additionally decreased their total FIM scores and affected the discrepancies between NIHSS scores. These findings suggest that age, PVH, history of heart disease positive, and bilateral infarction in patients with ischemic stroke affected their performance of ADLs and the discrepancies between their neurological severities in convalescent rehabilitation outcomes, probably because the pathophysiological background of leukoaraiosis and these factors strongly decrease their ADL performance in post-phase ischemic stroke.</p>","PeriodicalId":49014,"journal":{"name":"Nagoya Journal of Medical Science","volume":"85 3","pages":"428-443"},"PeriodicalIF":0.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/06/8e/2186-3326-85-0428.PMC10565594.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41217145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world effectiveness of ustekinumab for patients with ulcerative colitis: a systematic review and meta-analysis. ustekinumab治疗溃疡性结肠炎患者的真实疗效:一项系统综述和荟萃分析。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2023-08-01 DOI: 10.18999/nagjms.85.3.402
Genta Uchida, Masanao Nakamura, Takeshi Yamamura, Tomoyuki Tsuzuki, Hiroki Kawashima

Ustekinumab has recently been approved for the treatment of ulcerative colitis (UC) based on data from clinical trials. However, the effectiveness of ustekinumab in patients with UC in a real-world setting remains unclear. Hence, in this meta-analysis, we aimed to evaluate the effectiveness of ustekinumab in a real-world setting and to investigate the predictors of its effectiveness. A comprehensive literature search was performed to examine the effectiveness of ustekinumab in UC patients admitted between January 2019 and December 2021. Data on clinical remission, response, and corticosteroid-free clinical remission rates were extracted, pooled, and analyzed. Meta-regression analysis was performed to investigate the source of heterogeneity and the impact of moderators on the outcomes of interest. A total of 14 eligible studies were identified. The pooled clinical remission rate was 55.0% at week 8, 36.1% at week 16, 46.6% at month 6, and 38.6% at month 12. The meta-regression analysis showed that prior use of anti-tumor necrosis factor (TNF) agents and vedolizumab and the publication style were significant moderators. Additionally, out of 258 patients, there were 28 adverse events (AEs) (10.9%). The effectiveness of ustekinumab in real-world patients with UC was consistent with the results clinical trials. Moreover, previous treatment with anti-TNF agents and vedolizumab might have affected the effectiveness of ustekinumab.

根据临床试验数据,Ustekinumab最近被批准用于治疗溃疡性结肠炎(UC)。然而,在现实世界中,ustekinumab对UC患者的有效性仍不清楚。因此,在这项荟萃分析中,我们旨在评估ustekinumab在现实世界中的有效性,并研究其有效性的预测因素。对2019年1月至2021年12月期间入院的UC患者进行了全面的文献检索,以检查ustekinumab的有效性。提取、汇总和分析临床缓解率、反应率和无皮质类固醇临床缓解率的数据。进行荟萃回归分析,以调查异质性的来源以及调节因子对感兴趣结果的影响。共确定了14项符合条件的研究。合并临床缓解率在第8周为55.0%,在第16周为36.1%,在第6个月为46.6%,在第12个月为38.6%。荟萃回归分析显示,既往使用抗肿瘤坏死因子(TNF)药物和维多利珠单抗以及发表方式是显著的调节因素。此外,在258名患者中,有28例不良事件(AE)(10.9%)。ustekinumab在现实世界UC患者中的有效性与临床试验结果一致。此外,先前使用抗TNF药物和维多利珠单抗的治疗可能会影响ustekinumab的有效性。
{"title":"Real-world effectiveness of ustekinumab for patients with ulcerative colitis: a systematic review and meta-analysis.","authors":"Genta Uchida,&nbsp;Masanao Nakamura,&nbsp;Takeshi Yamamura,&nbsp;Tomoyuki Tsuzuki,&nbsp;Hiroki Kawashima","doi":"10.18999/nagjms.85.3.402","DOIUrl":"10.18999/nagjms.85.3.402","url":null,"abstract":"<p><p>Ustekinumab has recently been approved for the treatment of ulcerative colitis (UC) based on data from clinical trials. However, the effectiveness of ustekinumab in patients with UC in a real-world setting remains unclear. Hence, in this meta-analysis, we aimed to evaluate the effectiveness of ustekinumab in a real-world setting and to investigate the predictors of its effectiveness. A comprehensive literature search was performed to examine the effectiveness of ustekinumab in UC patients admitted between January 2019 and December 2021. Data on clinical remission, response, and corticosteroid-free clinical remission rates were extracted, pooled, and analyzed. Meta-regression analysis was performed to investigate the source of heterogeneity and the impact of moderators on the outcomes of interest. A total of 14 eligible studies were identified. The pooled clinical remission rate was 55.0% at week 8, 36.1% at week 16, 46.6% at month 6, and 38.6% at month 12. The meta-regression analysis showed that prior use of anti-tumor necrosis factor (TNF) agents and vedolizumab and the publication style were significant moderators. Additionally, out of 258 patients, there were 28 adverse events (AEs) (10.9%). The effectiveness of ustekinumab in real-world patients with UC was consistent with the results clinical trials. Moreover, previous treatment with anti-TNF agents and vedolizumab might have affected the effectiveness of ustekinumab.</p>","PeriodicalId":49014,"journal":{"name":"Nagoya Journal of Medical Science","volume":"85 3","pages":"402-427"},"PeriodicalIF":0.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/88/f5/2186-3326-85-0402.PMC10565585.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41217154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare case of the axillary necrotizing fasciitis. 罕见的腋窝坏死性筋膜炎。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2023-08-01 DOI: 10.18999/nagjms.85.3.619
Hiroki Ito, Shinsuke Takeda, Yuji Matsuno, Hiroshi Takahashi, Ken-Ichi Yamauchi

Necrotizing fasciitis is a rapidly progressive, life-threatening soft tissue infection that needs acute surgical intervention and other types of supportive care. The upper extremities are a less frequent site for this infection than the lower extremities. Axillary necrotizing fasciitis is quite rare and bears a high risk of iatrogenic neurovascular injuries. We report a severe case of a 39-year-old man with a right axillary necrotizing fasciitis caused by Streptococcus pyogenes. While dealing with important nerves and blood vessels at the initial emergency surgery, we marked and preserved them with vascular tapes. The patient underwent several surgical interventions for infection control in addition to supportive care to avoid limb loss and to survive. Intraoperatively, the locations of nerves and vessels could be easily found by checking the vessel tapes. Twelve months after the initial admission, the patient had no symptoms of nerve injuries and resumed work. With necrotizing fasciitis, the risk of an iatrogenic nerve injury exists even if limb amputation is avoided due to repeated debridement. We report that marking and preserving nerves and blood vessels with vascular tapes at the initial surgery may make the subsequent ones easier and may reduce iatrogenic neurovascular injury.

坏死性筋膜炎是一种进展迅速、危及生命的软组织感染,需要急性手术干预和其他类型的支持性护理。与下肢相比,上肢感染的频率较低。Axiillary坏死性筋膜炎非常罕见,并且具有医源性神经血管损伤的高风险。我们报告了一个39岁的严重病例,他患有由化脓性链球菌引起的右腋下坏死性筋膜炎。在最初的紧急手术中处理重要的神经和血管时,我们用血管带对其进行标记和保存。除了支持性护理外,患者还接受了几次控制感染的手术干预,以避免肢体丧失并存活下来。术中,通过检查血管带可以很容易地找到神经和血管的位置。首次入院12个月后,患者没有神经损伤症状,并恢复了工作。对于坏死性筋膜炎,即使由于反复清创而避免了截肢,也存在医源性神经损伤的风险。我们报告说,在初次手术时用血管带标记和保存神经和血管,可以使后续手术更容易,并可以减少医源性神经血管损伤。
{"title":"A rare case of the axillary necrotizing fasciitis.","authors":"Hiroki Ito,&nbsp;Shinsuke Takeda,&nbsp;Yuji Matsuno,&nbsp;Hiroshi Takahashi,&nbsp;Ken-Ichi Yamauchi","doi":"10.18999/nagjms.85.3.619","DOIUrl":"10.18999/nagjms.85.3.619","url":null,"abstract":"<p><p>Necrotizing fasciitis is a rapidly progressive, life-threatening soft tissue infection that needs acute surgical intervention and other types of supportive care. The upper extremities are a less frequent site for this infection than the lower extremities. Axillary necrotizing fasciitis is quite rare and bears a high risk of iatrogenic neurovascular injuries. We report a severe case of a 39-year-old man with a right axillary necrotizing fasciitis caused by <i>Streptococcus pyogenes</i>. While dealing with important nerves and blood vessels at the initial emergency surgery, we marked and preserved them with vascular tapes. The patient underwent several surgical interventions for infection control in addition to supportive care to avoid limb loss and to survive. Intraoperatively, the locations of nerves and vessels could be easily found by checking the vessel tapes. Twelve months after the initial admission, the patient had no symptoms of nerve injuries and resumed work. With necrotizing fasciitis, the risk of an iatrogenic nerve injury exists even if limb amputation is avoided due to repeated debridement. We report that marking and preserving nerves and blood vessels with vascular tapes at the initial surgery may make the subsequent ones easier and may reduce iatrogenic neurovascular injury.</p>","PeriodicalId":49014,"journal":{"name":"Nagoya Journal of Medical Science","volume":"85 3","pages":"619-625"},"PeriodicalIF":0.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b9/18/2186-3326-85-0619.PMC10565591.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41217144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Local hyperthermia with built-in endoscopy for radioresistant cervical cancer: a case series. 内置内窥镜局部热疗治疗抗辐射宫颈癌症:病例系列。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2023-08-01 DOI: 10.18999/nagjms.85.3.639
Nobuhisa Yoshikawa, Yoshiyuki Itoh, Tetsuya Matsukawa, Mariko Kawamura, Keiichiro Yamada, Seiji Nakamura, Hiroaki Kajiyama

We evaluated the efficacy and safety of an endoscope-embedded transvaginal laser hyperthermia system for superficial cervical cancer that remained in the cervix after radiotherapy. We developed an innovative endoscope-embedded hyperthermia system consisting of a diode laser device, a temperature control unit, an endoscope control unit, and a transvaginal probe. Superficial lesions of recurrent or residual cervical cancer on the uterine cervix or vaginal wall after radiotherapy were eligible for this study. A total of four cases of three patients were eligible for this treatment. Case 1: The post-chemoradiotherapy residual tumor of a patient with stage IIB squamous cell carcinoma of the cervix was treated with the device. Two months after the laser hyperthermia treatment, the tumor's disappearance was confirmed. Case 2: A post-hysterectomy persistent tumor on the vaginal stump of a patient with stage IIB adenocarcinoma of the cervix was subjected to the laser hyperthermia treatment. Two months after the treatment, the stump's cytology was false positive. Case 3: As in case 2, this patient's recurrence in the anterior vaginal wall was subjected to laser hyperthermia treatment, but the tumor's growth was not controlled. Case 4: A tumor at the vaginal margin was identified during a salvage hysterectomy in a patient with stage IIB squamous cell carcinoma of the cervix who underwent chemoradiotherapy. After laser hyperthermia treatment, the tumor's disappearance was confirmed. Our new endoscope-embedded laser hyperthermia system can be a candidate for treating residual superficial cervical cancer after radiotherapy by accurately capturing superficial lesions.

我们评估了内窥镜-经阴道激光热疗系统治疗放疗后残留在宫颈中的浅表癌症的有效性和安全性。我们开发了一种创新的内窥镜嵌入式热疗系统,该系统由二极管激光设备、温度控制单元、内窥镜控制单元和经阴道探头组成。放疗后宫颈或阴道壁上复发或残留宫颈癌症的浅表病变符合本研究的条件。共有四例三名患者符合此治疗条件。病例1:用该装置治疗一名IIB期宫颈鳞状细胞癌患者的放化疗后残留肿瘤。激光热疗两个月后,肿瘤消失了。病例2:对一名宫颈IIB期腺癌患者的子宫切除术后阴道残端的持续性肿瘤进行激光热疗治疗。治疗两个月后,残端细胞学检查呈假阳性。病例3:与病例2一样,对该患者阴道前壁复发进行了激光热疗治疗,但肿瘤的生长没有得到控制。病例4:在一名接受放化疗的IIB期宫颈鳞状细胞癌患者的挽救性子宫切除术中,发现阴道边缘有肿瘤。经过激光热疗,肿瘤消失了。我们新的内窥镜埋置激光热疗系统可以通过准确捕捉表面病变,成为治疗放疗后残留的癌症的候选系统。
{"title":"Local hyperthermia with built-in endoscopy for radioresistant cervical cancer: a case series.","authors":"Nobuhisa Yoshikawa,&nbsp;Yoshiyuki Itoh,&nbsp;Tetsuya Matsukawa,&nbsp;Mariko Kawamura,&nbsp;Keiichiro Yamada,&nbsp;Seiji Nakamura,&nbsp;Hiroaki Kajiyama","doi":"10.18999/nagjms.85.3.639","DOIUrl":"10.18999/nagjms.85.3.639","url":null,"abstract":"<p><p>We evaluated the efficacy and safety of an endoscope-embedded transvaginal laser hyperthermia system for superficial cervical cancer that remained in the cervix after radiotherapy. We developed an innovative endoscope-embedded hyperthermia system consisting of a diode laser device, a temperature control unit, an endoscope control unit, and a transvaginal probe. Superficial lesions of recurrent or residual cervical cancer on the uterine cervix or vaginal wall after radiotherapy were eligible for this study. A total of four cases of three patients were eligible for this treatment. Case 1: The post-chemoradiotherapy residual tumor of a patient with stage IIB squamous cell carcinoma of the cervix was treated with the device. Two months after the laser hyperthermia treatment, the tumor's disappearance was confirmed. Case 2: A post-hysterectomy persistent tumor on the vaginal stump of a patient with stage IIB adenocarcinoma of the cervix was subjected to the laser hyperthermia treatment. Two months after the treatment, the stump's cytology was false positive. Case 3: As in case 2, this patient's recurrence in the anterior vaginal wall was subjected to laser hyperthermia treatment, but the tumor's growth was not controlled. Case 4: A tumor at the vaginal margin was identified during a salvage hysterectomy in a patient with stage IIB squamous cell carcinoma of the cervix who underwent chemoradiotherapy. After laser hyperthermia treatment, the tumor's disappearance was confirmed. Our new endoscope-embedded laser hyperthermia system can be a candidate for treating residual superficial cervical cancer after radiotherapy by accurately capturing superficial lesions.</p>","PeriodicalId":49014,"journal":{"name":"Nagoya Journal of Medical Science","volume":"85 3","pages":"639-647"},"PeriodicalIF":0.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c9/50/2186-3326-85-0639.PMC10565581.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41217151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac rehabilitation in a heart-failure patient using customized "cardiac support net" treatment: a case report. 使用定制的“心脏支持网”治疗心力衰竭患者的心脏康复:一例报告。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2023-08-01 DOI: 10.18999/nagjms.85.3.626
Kiyonori Kobayashi, Toshiaki Akita, Sho Akita, Hideki Ito, Sachie Terazawa, Masato Mutsuga, Akihiko Usui

At our hospital, we are conducting the "Clinical Study of a Patient-Specific Cardiac Support Net for Dilated Cardiomyopathy (jRCTs042180025)", a multi-facility clinical study of a customized cardiac support net (CSN). Here, we describe the cardiac rehabilitation (CR) of a heart failure (HF) patient after CSN treatment. The patient was a 65-year-old man who exhibited dilated cardiomyopathy (DCM) because of left ventricular non-compaction; his New York Heart Association status was class III. In November 2019, he received CSN treatment. The early CR program was adapted for this patient, and his postoperative course was uneventful. Functional measurements showed improved leg-muscle strength (before treatment: 61.4% BW; at discharge: 77.3% BW). During long-term follow-up, the patient's exercise tolerance increased, as shown by 6-minute walk distance (before treatment: 576 m; long-term follow-up: 600 m) and peak oxygen uptake (before treatment: 12.5 mL/kg/min; long-term follow-up: 13.3 mL/kg/min). In the 2 years since discharge, the patient has not been hospitalized for HF. This report is the first to show that the CSN can be used to perform a CR program in a DCM patient without significant functional decline.

在我们医院,我们正在进行“扩张型心肌病患者专用心脏支持网的临床研究(jRCTs042180025)”,这是一项定制心脏支持网(CSN)的多设施临床研究。在这里,我们描述了CSN治疗后心力衰竭(HF)患者的心脏康复(CR)。患者是一名65岁的男性,因左心室不实而表现为扩张型心肌病(DCM);他的纽约心脏协会状态为III级。2019年11月,他接受了CSN治疗。早期CR程序适用于该患者,其术后过程平静。功能测量显示腿部肌肉力量有所改善(治疗前:61.4%体重;出院时:77.3%体重)。在长期随访期间,患者的运动耐受性增加,如6分钟步行距离(治疗前:576米;长期随访:600米)和峰值摄氧量(治疗前,12.5 mL/kg/min;长期随访,13.3 mL/kg/mn)所示。在出院后的2年内,患者没有因HF住院。本报告首次表明,CSN可用于DCM患者的CR程序,而不会出现显著的功能下降。
{"title":"Cardiac rehabilitation in a heart-failure patient using customized \"cardiac support net\" treatment: a case report.","authors":"Kiyonori Kobayashi,&nbsp;Toshiaki Akita,&nbsp;Sho Akita,&nbsp;Hideki Ito,&nbsp;Sachie Terazawa,&nbsp;Masato Mutsuga,&nbsp;Akihiko Usui","doi":"10.18999/nagjms.85.3.626","DOIUrl":"10.18999/nagjms.85.3.626","url":null,"abstract":"<p><p>At our hospital, we are conducting the \"Clinical Study of a Patient-Specific Cardiac Support Net for Dilated Cardiomyopathy (jRCTs042180025)\", a multi-facility clinical study of a customized cardiac support net (CSN). Here, we describe the cardiac rehabilitation (CR) of a heart failure (HF) patient after CSN treatment. The patient was a 65-year-old man who exhibited dilated cardiomyopathy (DCM) because of left ventricular non-compaction; his New York Heart Association status was class III. In November 2019, he received CSN treatment. The early CR program was adapted for this patient, and his postoperative course was uneventful. Functional measurements showed improved leg-muscle strength (before treatment: 61.4% BW; at discharge: 77.3% BW). During long-term follow-up, the patient's exercise tolerance increased, as shown by 6-minute walk distance (before treatment: 576 m; long-term follow-up: 600 m) and peak oxygen uptake (before treatment: 12.5 mL/kg/min; long-term follow-up: 13.3 mL/kg/min). In the 2 years since discharge, the patient has not been hospitalized for HF. This report is the first to show that the CSN can be used to perform a CR program in a DCM patient without significant functional decline.</p>","PeriodicalId":49014,"journal":{"name":"Nagoya Journal of Medical Science","volume":"85 3","pages":"626-634"},"PeriodicalIF":0.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/40/8f/2186-3326-85-0626.PMC10565582.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41217147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Nagoya Journal of Medical Science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1